1. Home
  2. SLND vs EDIT Comparison

SLND vs EDIT Comparison

Compare SLND & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$3.33

Market Cap

178.6M

Sector

Industrials

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.42

Market Cap

233.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLND
EDIT
Founded
1900
2013
Country
United States
United States
Employees
2100
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.6M
233.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SLND
EDIT
Price
$3.33
$2.42
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$4.00
$4.13
AVG Volume (30 Days)
67.6K
1.7M
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$935,461,000.00
$46,383,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$0.91
52 Week High
$5.34
$4.54

Technical Indicators

Market Signals
Indicator
SLND
EDIT
Relative Strength Index (RSI) 41.15 42.37
Support Level $3.09 $2.09
Resistance Level $3.42 $2.55
Average True Range (ATR) 0.19 0.17
MACD 0.03 0.02
Stochastic Oscillator 80.70 51.56

Price Performance

Historical Comparison
SLND
EDIT

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: